posted on 2016-04-19, 00:00authored byXinghua Zhang, Barbara Blasiak, Armando J. Marenco, Simon Trudel, Boguslaw Tomanek, Frank C. J. M. van Veggel
Lanthanide-based (Ln3+-based) nanoparticles have great
potential for high-field magnetic resonance imaging (MRI) applications.
Here, we report NaHoF4 and NaDyF4 nanoparticles
with modulated sizes (9–40 nm) and shapes (spherical-like,
hexagonal prism, rod-like), suitable for high-field MRI as shown through in vivo studies. We used X-ray diffraction, transmission
electron microscope, dynamic light scattering, and MRI techniques
to investigate the structure, morphology, hydrodynamic size, and relaxivity
of the prepared NaHoF4 and NaDyF4 nanoparticles,
showing monodisperse nanoparticles of high crystallinity. In particular,
we studied effects of the particle size, shape, surface coating and
ζ-potential on transverse (spin–spin relaxivity, r2) and longitudinal (spin–lattice relaxivity, r1) relaxivity at 9.4 T. We found that the NaHoF4 and NaDyF4 nanoparticles have r2 relaxivities of (274.0 ± 6.9) × 104 and (4767.3 ± 160.9) × 104 mMNP–1 s–1 per nanoparticle and high r2/r1 ratio of 781
and 410 at a high magnetic field of 9.4 T, respectively, making them
attractive as MRI T2 contrast agents.
The growth of the hexagonal structure of the NaHoF4 and
NaDyF4 nanoparticles was mainly dominated by the growth
competition along the [001] and [100] directions that could be modulated
by the amount of oleic acid (OA), 1-octadecene (ODE), NaOH, and NH4F. Moreover, both the larger particle size and thin coating
polymer layer of nanoparticles increased the transverse relaxivity.
The effects of the parameters, such as rotation correlation time,
diffusion, and electronic relation times on the dipolar and Curie
components of the inner- and outer-sphere contribution, and thus directly
on the relaxivity, are discussed. We found that these parameters can
be modulated by the particle size and surface coating. Following the
outer-sphere relaxation theory, we used computer simulations of r1 and r2 relaxivity
as a function of the particle core size, hydrodynamic size, diffusion
time, and electronic relation time, which all show an impact on r1 and r2, albeit
to very different extends, which has enhanced our understanding of
the relaxivity mechanisms. According to the computer simulations, r1 can be controlled by the core size, hydrodynamic
size at low magnetic fields of ∼0.02 T corresponding to proton
Larmor frequency of about 1 MHz. The r1 does not change significantly at the higher frequency and actually
drops precipitously. However, on the basis of theoretical simulations,
we expect r2 can be increased in a wide
range of Larmor frequencies (0.1–1000 MHz) by increasing the
core size, reducing thickness of the coating layer, or increasing
the magnetic field. The particle sizes, hydrodynamic sizes, and diffusion
times and magnetic fields have larger contribution to the relaxivity
than that of other parameters. Five animals were imaged and in vivo MRI showed that the rod-like NaDyF4 (25
nm × 35 nm) nanoparticles, without any targeting ligands, provided
visible contrast between brain and breast tumors and normal tissues
up to 24 h after injection. Contrast was observed in all animals after
injection of nanoparticle solution, which may be attributed to enhanced
permeation and retention effects of the rod-shape nanoparticles in
tumor. The experimental and simulation results suggest that the NaHoF4 and NaDyF4 nanoparticles are indeed good candidates
for high-field (>3 T) T2 imaging contrast
agents.